Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

NCT06455293 is registered in ClinicalTrials.gov with Joshua Woolley, MD, PhD as lead sponsor.

NCT NCT06455293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06455293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Lead sponsor
Joshua Woolley, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
August 19, 2024
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, parkinson disease